Premium
Continuous treatment with Ibrutinib in 100 untreated patients with TP 53 disrupted chronic lymphocytic leukemia: A real‐life campus CLL study
Author(s) -
Visentin Andrea,
Mauro Francesca Romana,
Cibien Francesca,
Vitale Candida,
Reda Gianluigi,
Fresa Alberto,
Ciolli Stefania,
Pietrasanta Daniela,
Marchetti Monia,
Murru Roberta,
Gentile Massimo,
Rigolin Gian Matteo,
Quaglia Francesca Maria,
Scarfò Lydia,
Sportoletti Paolo,
Pravato Stefano,
Piazza Francesco,
Coscia Marta,
Laurenti Luca,
Molica Stefano,
Foà Robin,
Cuneo Antonio,
Trentin Livio
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26437
Subject(s) - ibrutinib , chronic lymphocytic leukemia , medicine , leukemia , oncology , bruton's tyrosine kinase , tyrosine kinase , receptor